Thirty years of recombinant BCG: new trends for a centenary vaccine-Reference-Cited by-同舟云学术

Thirty years of recombinant BCG: new trends for a centenary vaccine

Published:2021-07-13 Issue:8 Volume:20 Page:1001-1011
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Marques-Neto Lazaro M¹,Piwowarska Zuzanna¹²,Kanno Alex I.¹^ORCID,Moraes Luana¹³,Trentini Monalisa M¹,Rodriguez Dunia¹,Silva Jose L. S. C.¹³,Leite Luciana C. C.¹^ORCID

Affiliation:

1. Laboratório De Desenvolvimento De Vacinas, Instituto Butantan, São Paulo, Brazil

2. UnivLyon, Université Claude Bernard Lyon 1, Villeurbanne, France

3. Programa De Pós-Graduação Interunidades Em Biotecnologia USP-Instituto Butantan-IPT, São Paulo, Brazil

Funder

FAPESP

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2021.1951243

Reference108 articles.

1. BCG: who were Calmette and Guerin?

2. Correspondence

3. Office WHOTR, Campaign IT Mass BCG vaccination campaigns: 1948-1951/reports prepared by the tuberculosis research office, World Health Organization [internet]. Copenhagen: International Tuberculosis Campaign; Available from: https://apps.who.int/iris/handle/10665/62743

4. WHO Expert Committee on biological standardization [meeting held in Geneva from 28 November to 3 December 1966]: nineteenth report [internet]; 1967. Available from: https://apps.who.int/iris/handle/10665/40655

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of CRISPR–cas-based technology for the identification of tuberculosis, drug discovery and vaccine development;Molecular Biology Reports;2024-03-29

2. Construction of rBCG carrying the IL-2-BZLF1 fusion gene and its immunological function;Applied Microbiology and Biotechnology;2024-01-03

3. Comparison of the Immunogenicity and Efficacy of rBCG-EPCP009, BCG Prime-EPCP009 Booster, and EPCP009 Protein Regimens as Tuberculosis Vaccine Candidates;Vaccines;2023-11-22

4. Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies;Frontiers in Immunology;2023-08-03

5. Challenges and Strategies for Developing Recombinant Vaccines against Leptospirosis: Role of Expression Platforms and Adjuvants in Achieving Protective Efficacy;Pathogens;2023-05-31